Is Zentalis Pharmaceuticals, Inc. (ZNTL) a Buy, Sell, or Hold?
NASDAQ : ZNTL
Zentalis Pharmaceuticals, Inc. — Competitors
$4.22 USD
-$0.78 (-15.6%)
- Volume
- 1.58M
- Average Volume
- 1.17M
- Market Capitalization
- $300.41M
- P/E Ratio
- -1.72
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $6.95
- Year Low
- $1.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.82
ZNTL vs. The Competition
| Properties | ZNTL | ALXO | ARTV | DTIL |
|---|---|---|---|---|
| Market Cap | $300.41M | $282.58M | $278.56M | $96.08M |
| Shares Outstanding | $71.19M | $134.56M | $24.72M | $12.83M |
| P/E Ratio | -1.72 | -1.63 | -3.4 | -2.68 |
| EPS | -2.49 | -0.6 | -2.3 | -2.04 |
| Day Low | 4.01 | 2.04 | 10.75 | 7.392 |
| Day High | 4.8255 | 2.1799 | 11.98 | 7.705 |
| Year Low | 1.212 | 0.601 | 2.22 | 3.53 |
| Year High | 6.95 | 2.66 | 14.53 | 9.62 |
| Average Price 50 | 4.3111 | 1.8864 | 9.283 | 7.3362 |
| Average Price 200 | 3.01408 | 1.76975 | 6.665 | 6.04708 |
| Volume | 1.58M | 8.49M | 207.77K | 239.58K |
| Average Volume | - | - | - | - |